Home Overview Press Room Blog Publications For Students about us
Search

News Article

Scientists are trying to use CRISPR to fix everything. What’s wrong with that?by Emily McManusTED IdeasMay 5th, 2016A historian of eugenics asks: "Will individuals start making decisions to use new biotech to improve themselves and their children?"
The World’s Most Expensive Medicine Is a Bustby Antonio RegaladoMIT Technology ReviewMay 5th, 2016The first gene therapy approved in the Western world costs $1 million and has been used just once.
I Want To Put A Baby In You: The Curious Case Of Louisianaby Ellen TrachmanAbove the LawMay 4th, 2016Instead of reasonable regulation, the pending Louisiana bill transparently limits the types of people who can enter surrogacy arrangements.
Google's DeepMind shouldn't suck up our NHS records in secretby Randeep RameshThe Guardian [US]May 4th, 2016The revelation that 1.6 million patients’ records are being used by the company’s artificial intelligence arm rings alarm bells.
Why this lab-grown human embryo has reignited an old ethical debate[citing CGS' Marcy Darnovsky]by Patrick MonahanScience/AAASMay 4th, 2016Two teams report growing human embryos just up to 14 days, prompting some scientists and bioethicists to contend that it’s time to revisit the so-called 14-day rule.
New advances in growing human embryos could prompt ethical firestorm[citing CGS' Marcy Darnovsky]by Eric BoodmanSTATMay 4th, 2016Changing the 14-day rule is an explosive question in an era when CRISPR gene-editing has sparked fears about “designer babies.”
Cultural Influences Reflected in Divergent US vs UK Human Embryo Research Policies[citing CGS' Marcy Darnovsky]by Eli Y. AdashiThe JAMA ForumMay 3rd, 2016Reactions to CRISPR gene editing experiments depend upon a country's existing laws and regulation.
Dead could be brought 'back to life' in groundbreaking projectby Sarah KnaptonThe Telegraph [UK]May 3rd, 2016A US biotech firm received permission to recruit 20 clinically dead patients for a stem cell treatment.
The gene editor CRISPR won’t fully fix sick people anytime soon. Here’s whyby Jocelyn KaiserScience/AAASMay 3rd, 2016After more than two decades of ups and downs, veterans of the gene therapy field are wary of raising expectations about CRISPR for treating diseases.
As China’s one-child policy ends, surrogacy services rise in the U.S.by Kevin SmithSan Gabriel Valley TribuneApril 30th, 2016“I’ve been contacted by 15 to 18 agencies out of China... 90 percent of them don’t have any patients. They’re just new agencies trying to make a buck."
Displaying 1-10 of 4378  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760